Brief: Hemostemix Announces Resignation Of Don Friesen From Board, Effective Nov. 21
22/11/2019 21:37
Nov 22 (Reuters) - Hemostemix Inc HEM.V :
* HEMOSTEMIX ANNOUNCES DIRECTOR RESIGNATION
* HEMOSTEMIX INC - ANNOUNCES RESIGNATION OF DON FRIESEN FROM
COMPANY'S BOARD EFFECTIVE NOVEMBER 21
* HEMOSTEMIX INC - AS A RESULT OF RESIGNATION OF FRIESEN, CO
HAS 2
REMAINING DIRECTORS, ANGUS JENKINS AND DAVID WOOD, AND IS IN
BREACH OF TSXV POLICIES
Source text for Eikon: ID:nGNX3S3Zmx
Further company coverage: HEM.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Hemostemix
See all newsBrief: Hemostemix Announces Financing Update And Secured Convertible Debenture Financing Of Up To $2,000,000
Brief: Aspire Health Science Files Supplemental Motion For Expedited Hearing In Lawsuit Against Hemostemix Inc. And Suspends Patient Recruitment For Hemostemix Cli Phase 2 Clinical Trial
Brief: Aspire Health Sciences Says On Jan 28, 2020, Initiated Legal Proceeding Against Hemostemix Inc
Brief: Hemostemix Announces Private Placement
Brief: Hemostemix Announces Corporate Update